Is A Fall Imminent For Teva Stock After Its Recent Rally? | Trefis
Teva Avoids Bankruptcy, Huge Upside (NYSE:TEVA) | Seeking Alpha
Teva: Warren Buffett Likely Made A Mistake Selling Shares | Seeking Alpha
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Teva Reports First Quarter 2020 Financial Results | Business Wire
Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says - Bloomberg
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva Stock Skyrockets After Inking North Of $4 Billion In Opioid Settlements | Investor's Business Daily
Will Teva Stock Rebound After A 10% Fall In A Month?
'Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Is A Fall Imminent For Teva Stock After Its Recent Rally?
Hedge Funds Are Dipping Their Toes Into Teva Pharmaceutical Industries (TEVA )
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva puts further $468m aside for opioid settlements | Financial Times
Teva Pharmaceuticals Found Liable For Opioid Crisis by Jury, Trial Will Determine Penalty
Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Teva reaches $523 million deal to settle opioid lawsuit with New York | CNN Business
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
Teva Pays $420 Million to End Generic-Drug Securities Suit (1)
Teva to pay New York $500M for role in opioid crisis - POLITICO
Teva sells its only manufacturing plant in Russia
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva sees return to growth after opioid settlement, shares jump | Reuters
Teva Stock Skyrockets After Inking North Of $4 Billion In Opioid Settlements | Investor's Business Daily
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
